Regorafenib and Pembrolizumab in Treating Participants With Advanced or Metastatic Colorectal Cancer

NCT03657641 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

75

Enrollment

OTHER

Sponsor class

Conditions

Colorectal Cancer
Colorectal Cancer Metastatic

Interventions

BIOLOGICAL: Pembrolizumab
DRUG: Regorafenib

Sponsor

University of Southern California

Collaborators

[object Object]